Sisyrinchium aff. palmifolium Lovo 195

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-2017
01219912017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
OBJECTIVE To investigate the expression of acetyl coenzyme A synthetase short-chain family member 2 (ACSS2) in patients with… (More)
Is this relevant?
2014
2014
AIM To investigate the effects of osteopontin (OPN) gene expression knockdown on colon cancer Lovo cells in vitro. METHODS Four… (More)
Is this relevant?
2014
2014
BACKGROUND Multidrug resistance (MDR) is one of the major reasons chemotherapy-based treatments fail. Hypoxia is generally… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
OBJECTIVE To investigate the effects of Hic-5/ARA55 on the growth of the human colorectal cancer cells (Lovo cells) and its… (More)
Is this relevant?
1999
1999
The development of therapy-induced drug resistance is still one of the most important therapeutic limitations. Nevertheless, an… (More)
Is this relevant?
1996
1996
Idarubicin (IDA) is a daunorubicin (DAU) analog that is being used to treat a variety of human malignancies. The major… (More)
Is this relevant?
1995
1995
The MDR1 gene product P-glycoprotein is a plasma membrane efflux pump which is responsible for multiple drug resistance of cancer… (More)
Is this relevant?
1994
1994
Two human colon carcinoma drug resistant clones (LoVo-IDA-1 and LoVo-IDA-2) were selected by continuous pressure of LoVo parent… (More)
Is this relevant?
1993
1993
Human colon adenocarcinoma cells (LoVo) resistant to the new antitumor agent FCE 24517 [benzoyl-mustard derivative of distamycin… (More)
  • figure 1
  • figure 2
  • table I
  • table II
Is this relevant?
1991
1991
A human colon-carcinoma cell subline resistant to doxorubicin (LoVo/Dx), previously shown to be more lysed than the… (More)
Is this relevant?